David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jack Alan Reynolds
Learn more about PhilPapers
Ruth Chadwick, Henk ten Have, Rogeer Hoedemaekers, Jrgen Husted, Mairi Levitt, Tony McGleenan, Darren Shickle & Urban Wiesing
Journal of Medicine and Philosophy 26 (3):263 – 272 (2001)
The project Euroscreen 2 has examined genetic screening and testing with particular reference to implications for insurance, commercialization through marketing of genetic tests direct to the public, and issues surrounding raising public awareness of these and other developments in genetics, including the practical experiment of a Gene Shop. This paper provides a snapshot of the three year project. The study groups work included monitoring developments in different European countries and exploring possibilities for regulation in insurance and commercialization together with public attitudes to regulation. The success or failure of different strategies is not independent of public awareness. Exploration of policy, however, also requires examination of fundamental concepts such as solidarity and geneticization.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
V. Launis (2000). The Use of Genetic Test Information in Insurance: The Argument From Indistinguishability Reconsidered. Science and Engineering Ethics 6 (3):299-310.
Robert H. Blank (1982). Public Policy Implications of Human Genetic Technology: Genetic Screening. Journal of Medicine and Philosophy 7 (4):355-374.
Renee Kyle & Susan Dodds (2009). Avoiding Empty Rhetoric: Engaging Publics in Debates About Nanotechnologies. Science and Engineering Ethics 15 (1):81-96.
William M. Sage (2010). Will Embryonic Stem Cells Change Health Policy? Journal of Law, Medicine & Ethics 38 (2):342-351.
Ruth Chadwick, Henk ten Have, Jfrgen Husted, Mairi Levitt, Tony McGleenan, Darren Shickle & Urban Wiesing (1998). Genetic Screening and Ethics: European Perspectives. Journal of Medicine and Philosophy 23 (3):255 – 273.
Patrick L. Brockett & E. Susan Tankersley (1997). The Genetics Revolution, Economics, Ethics and Insurance. Journal of Business Ethics 16 (15):1661-1676.
Benjamin Hale (2009). What's so Moral About the Moral Hazard? Public Affairs Quarterly 23 (1):1-26.
Mairi Levitt (2003). Public Consultation in Bioethics. What's the Point of Asking the Public When They Have Neither Scientific nor Ethical Expertise? Health Care Analysis 11 (1):15-25.
Shaheen Borna & Stephen Avila (1999). Genetic Information: Consumers' Right to Privacy Versus Insurance Companies' Right to Know a Public Opinion Survey. [REVIEW] Journal of Business Ethics 19 (4):355 - 362.
Added to index2009-01-28
Total downloads6 ( #380,674 of 1,781,335 )
Recent downloads (6 months)1 ( #295,021 of 1,781,335 )
How can I increase my downloads?